StockWireNews
Low Float Biotech Profile On The Way - Two February Profiles Run Approx. 216% Combined
Full Report Arrives At 8:00PM EST Tonight Or 9:30AM EST Tomorrow
Sign Up To My SMS Update System - Directions Below
February 14th
Greetings Readers,
Listen. You may as well sit down. We have a lot to go over.
First off, we need to take a quick trip down memory lane.
On February 2nd, I delivered a Nasdaq Biotech profile.
That day it opened at $1.13. Fast forward to February 10th... Boom. An astonishing high of $2.65.
134% (approx.) just like that. Solid stuff, but that's not all.
My February 6th profile, an OTCQB Biotech, ran from that day's open of $.319 to a February 9th high of $.5827.
More math? Sure. That's a 4 day run of approximately 82%.
Incredible, right? Two ideas run approximately 216% combined.
Still trying to catch your breath?
Understandable, but don't take too long. At 8:00PM EST tonight or 9:30AM EST tomorrow, I'm bringing you a new Nasdaq Biotech idea.
In the full report arriving shortly, it'll detail just why you need to get this company on your radar faster than fast.
But until then, here's a few interesting tidbits to chew on. Check them out:
3 Key Potential Catalysts - New Nasdaq Breakout Idea For Wednesday
#1. The chance for volatility could be high. With a float of fewer than 5Mn shares, volatility could pop up at the drop of a hat (or positive company news).
#2. An explosive chart history with several monster rips. Taking a quick look at this profile's 1-year history shows a multitude of multi-dollar intraday/short term runs.
#3. This company recently became a dual-lister when it joined a new, interesting exchange.
The potential exposure? Maybe unquantifiable.
Do this:
